BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1283010)

  • 1. Intrathecal co-administration of substance P and NMDA augments nociceptive responses in the formalin test.
    Mjellem-Joly N; Lund A; Berge OG; Hole K
    Pain; 1992 Nov; 51(2):195-198. PubMed ID: 1283010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular messengers contributing to persistent nociception and hyperalgesia induced by L-glutamate and substance P in the rat formalin pain model.
    Coderre TJ; Yashpal K
    Eur J Neurosci; 1994 Aug; 6(8):1328-34. PubMed ID: 7526941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats.
    Malmberg AB; Yaksh TL
    Pain; 1993 Sep; 54(3):291-300. PubMed ID: 8233543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin (1-7) Attenuates the Nociceptive Behavior Induced by Substance P and NMDA via Spinal MAS1.
    Yamagata R; Nemoto W; Fujita M; Nakagawasai O; Tan-No K
    Biol Pharm Bull; 2021; 44(5):742-746. PubMed ID: 33952831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal antinociceptive effect of substance P on the responses induced by intrathecally injected NMDA in mice.
    Masuyama T; Shimizu T; Iwashita T; Yoshimura N; Fukuda T
    Brain Res; 1996 May; 722(1-2):200-2. PubMed ID: 8813368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats.
    Yashpal K; Fisher K; Chabot JG; Coderre TJ
    Pain; 2001 Oct; 94(1):17-29. PubMed ID: 11576741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Furuta S; Sato T; Satoh S; Yasuhara H; Tadano T
    J Pharmacol Sci; 2007 May; 104(1):39-45. PubMed ID: 17452810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of spinal cholera toxin- and pertussis toxin-sensitive G proteins in nociceptive responses caused by formalin, capsaicin, and substance P in mice.
    Chung KM; Lee KC; Choi SS; Suh HW
    Brain Res Bull; 2001 Mar; 54(5):537-42. PubMed ID: 11397545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evidence for involvement of excitatory amino acids in aversive responses induced by intrathecal substance P in rats.
    Okano K; Kuraishi Y; Satoh M
    Biol Pharm Bull; 1993 Sep; 16(9):861-5. PubMed ID: 7505686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models.
    Choi SS; Lee JK; Suh HW
    Brain Res; 2001 Dec; 921(1-2):233-9. PubMed ID: 11720731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of tonic nociceptive behavior using a method of substance P-receptor desensitization in the dorsal horn.
    Holland LN; Goldstein BD
    Pain; 1994 Mar; 56(3):339-346. PubMed ID: 7517516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
    Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
    J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive involvement of substance P in the spinal cord of mice: dose effects of substance P on the behavior elicited by intrathecally administered NMDA.
    Masuyama T; Shimizu T
    Brain Res; 1997 Jun; 759(2):241-6. PubMed ID: 9221943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mexiletine on formalin-induced nociceptive responses in mice.
    Kamei J; Hitosugi H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):153-62. PubMed ID: 7686682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of a behavioural response in mice by spinal coadministration of substance P and excitatory amino acid agonists.
    Mjellem-Joly N; Lund A; Berge OG; Hole K
    Neurosci Lett; 1991 Nov; 133(1):121-4. PubMed ID: 1724310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model.
    Murray CW; Cowan A; Larson AA
    Pain; 1991 Feb; 44(2):179-185. PubMed ID: 1711193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors.
    Du J; Zhou S; Coggeshall RE; Carlton SM
    Neuroscience; 2003; 118(2):547-62. PubMed ID: 12699789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive effect induced by intraperitoneal administration of vitamin K2 (menatetrenone) in ICR mice.
    Onodera K; Shinoda H; Zushida K; Taki K; Kamei J
    Life Sci; 2000 Nov; 68(1):91-7. PubMed ID: 11132249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central nucleus of the amygdala contributes to the production of morphine antinociception in the formalin test.
    Manning BH; Mayer DJ
    Pain; 1995 Nov; 63(2):141-152. PubMed ID: 8628579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of peripheral NMDA-nitric oxide cascade in formalin test.
    Omote K; Kawamata T; Kawamata M; Nakayama Y; Hazama K; Namiki A
    Anesthesiology; 2000 Jul; 93(1):173-8. PubMed ID: 10861161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.